![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication May 31, 2005.
Revised September 6, 2005.
Accepted for publication September 28, 2005.
Multidrug resistance-associated protein (Mrp) 2-deficient TR- rats, together with their transport-competent Wistar counterparts (wild-type), have been used to examine the contribution of Mrp2 to drug disposition. However, little is known about potential variation in expression of other transport proteins between TR- and wild-type rats, or whether these differences are tissue specific. Sections of liver, kidney, brain, duodenum, jejunum, ileum, and colon were obtained from male TR- and wild-type Wistar rats. Samples were homogenized in protease inhibitor cocktail and ultracentrifuged at 100,000g for 30 min to obtain membrane fractions. Mrp2, Mrp3, Mrp4, P-glycoprotein (P-gp), sodium-dependent taurocholate cotransporting polypeptide (Ntcp), organic anion transporting polypeptide (Oatp) 1a1 and 1a4, bile salt export pump (Bsep), breast cancer resistance protein (Bcrp), ileal bile acid transporter (Ibat), UDP-glucuronosyl transferase (UGT1a), glyceraldehyde-3-phosphate dehydrogenase, and 
-actin protein expression were determined by Western blot. Mrp3 was significantly up-regulated in the liver (~6-fold) and kidney (~3.5-fold) of TR- rats compared to wild-type controls. Likewise, the expression of UGT1a enzymes was increased in the liver and kidney of TR- rats, by ~3.5-fold and ~5.5-fold, respectively. Interestingly, Mrp3 expression was down-regulated in the small intestine of TR- rats, but expression was similar to wild-type in the colon. Mrp4 was expressed to varying extents along the intestine. Expression of some transport proteins and UGT1a enzymes differ significantly between TR- and wild-type rats. Therefore, altered drug disposition in TR- rats must be interpreted cautiously because up- or down-regulation of other transport proteins may play compensatory roles in the presence of Mrp2 deficiency.
Key words:
drug disposition, hepatobiliary transport, transporters, UDP glucuronyltransferases
This article has been cited by other articles:
|
|
 |
|
  D. R. de Waart, M. L. H. Vlaming, C. Kunne, A. H. Schinkel, and R. P. J. O. Elferink Complex Pharmacokinetic Behavior of Ezetimibe Depends on Abcc2, Abcc3, and Abcg2 Drug Metab. Dispos., August 1, 2009; 37(8): 1698 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Bhargava, B. Joseph, M. Ananthanarayanan, N. Balasubramaniyan, G. G. Tronco, C. J. Palestro, and S. Gupta Adenosine Triphosphate-Binding Cassette Subfamily C Member 2 Is the Major Transporter of the Hepatobiliary Imaging Agent 99mTc-Mebrofenin J. Nucl. Med., July 1, 2009; 50(7): 1140 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Arias, S. S. M. Villanueva, M. L. Ruiz, M. G. Luquita, L. M. Veggi, J. M. Pellegrino, M. Vore, V. A. Catania, and A. D. Mottino Regulation of Expression and Activity of Rat Intestinal Multidrug Resistance-Associated Protein 2 by Cholestatic Estrogens Drug Metab. Dispos., June 1, 2009; 37(6): 1277 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lecureux, M. Z. Dieter, D. M. Nelson, L. Watson, H. Wong, B. Gemzik, C. D. Klaassen, and L. D. Lehman-McKeeman Hepatobiliary Disposition of Thyroid Hormone in Mrp2-Deficient TR- Rats: Reduced Biliary Excretion of Thyroxine Glucuronide Does Not Prevent Xenobiotic-Induced Hypothyroidism Toxicol. Sci., April 1, 2009; 108(2): 482 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L.H. Vlaming, Z. Pala, A. van Esch, E. Wagenaar, O. van Tellingen, D. R. de Waart, R. P.J. Oude Elferink, K. van de Wetering, and A. H. Schinkel Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate Clin. Cancer Res., December 15, 2008; 14(24): 8152 - 8160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, M. Leggas, M. Goswami, P. E. Empey, and P. J. McNamara N-(4-[2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine Carboxamide (GF120918) As a Chemical ATP-Binding Cassette Transporter Family G Member 2 (Abcg2) Knockout Model to Study Nitrofurantoin Transfer into Milk Drug Metab. Dispos., December 1, 2008; 36(12): 2591 - 2596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Miranda, J. K. Lee, K. L. R. Brouwer, Z. Wen, P. C. Smith, and R. L. Hawke Hepatic Metabolism and Biliary Excretion of Silymarin Flavonolignans in Isolated Perfused Rat Livers: Role of Multidrug Resistance-Associated Protein 2 (Abcc2) Drug Metab. Dispos., November 1, 2008; 36(11): 2219 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Abe, A. S. Bridges, W. Yue, and K. L. R. Brouwer In Vitro Biliary Clearance of Angiotensin II Receptor Blockers and 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Inhibitors in Sandwich-Cultured Rat Hepatocytes: Comparison with in Vivo Biliary Clearance J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 983 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. MacLean, U. Moenning, A. Reichel, and G. Fricker Closing the Gaps: A Full Scan of the Intestinal Expression of P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance-Associated Protein 2 in Male and Female Rats Drug Metab. Dispos., July 1, 2008; 36(7): 1249 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. Westley, R. G. Morris, A. M. Evans, and B. C. Sallustio Glucuronidation of Mycophenolic Acid by Wistar and Mrp2-Deficient TR- Rat Liver Microsomes Drug Metab. Dispos., January 1, 2008; 36(1): 46 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Leslie, G. Ghibellini, K.-i. Nezasa, and K. L.R. Brouwer Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats Carcinogenesis, December 1, 2007; 28(12): 2650 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Kalgutkar, B. Feng, H. T. Nguyen, K. S. Frederick, S. D. Campbell, H. L. Hatch, Y.-A. Bi, D. C. Kazolias, R. E. Davidson, R. J. Mireles, et al. Role of Transporters in the Disposition of the Selective Phosphodiesterase-4 Inhibitor (+)-2-[4-({[2-(Benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic Acid in Rat and Human Drug Metab. Dispos., November 1, 2007; 35(11): 2111 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Enokizono, H. Kusuhara, and Y. Sugiyama Regional Expression and Activity of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Mouse Intestine: Overlapping Distribution with Sulfotransferases Drug Metab. Dispos., June 1, 2007; 35(6): 922 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Tallman, K. K. Miles, F. K. Kessler, J. N. Nielsen, X. Tian, J. K. Ritter, and P. C. Smith The Contribution of Intestinal UDP-Glucuronosyltransferases in Modulating 7-Ethyl-10-hydroxy-camptothecin (SN-38)-Induced Gastrointestinal Toxicity in Rats J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 29 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oswald, S. Westrup, M. Grube, H. K. Kroemer, W. Weitschies, and W. Siegmund Disposition and Sterol-Lowering Effect of Ezetimibe in Multidrug Resistance-Associated Protein 2-Deficient Rats J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1293 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liu, Y. Cui, A. Y. Chung, Y. Shitara, Y. Sugiyama, D. Keppler, and K. S. Pang Vectorial Transport of Enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in Rat and Human Livers J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 395 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Y. Chu, J. R. Strauss, M. A. Mariano, J. Li, D. J. Newton, X. Cai, R. W. Wang, J. Yabut, D. P. Hartley, D. C. Evans, et al. Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2) J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 579 - 589. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
